
Opinion|Videos|December 24, 2024
Overview of Novel Treatments for Retinal Vascular Diseases
A panelist discusses novel treatments for retinal vascular diseases, including faricimab, aflibercept, and port delivery system with ranibizumab.
Advertisement
Episodes in this series

Now Playing
Video content above is prompted by the following:
Could you briefly provide an overview of the new treatments available for retinal vascular diseases?
- Faricimab
- Aflibercept 8mg
- port delivery system with ranibizumab
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
First patient treated in ViaLase’s IDE trial
2
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
3
PainReform launches development plan for OcuRing-K, readies phase 2 trial
4
Formosa Pharmaceuticals and Rxilient sign licensing and commercialization agreement for APP13007
5















































.png)


